(Q43775324)

English

Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

26 November 2017

Kaposi's sarcoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Núñez

1

1 reference

Europe PubMed Central

26 November 2017

P Saballs

2

1 reference

Europe PubMed Central

26 November 2017

M E Valencia

3

1 reference

Europe PubMed Central

26 November 2017

J Santos

4

1 reference

Europe PubMed Central

26 November 2017

E Ferrer

5

1 reference

Europe PubMed Central

26 November 2017

I Santos

6

1 reference

Europe PubMed Central

26 November 2017

A Berrocal

7

1 reference

Europe PubMed Central

26 November 2017

M J Galindo

8

1 reference

Europe PubMed Central

26 November 2017

D Podzamczer

9

1 reference

Europe PubMed Central

26 November 2017

J Gonzlez-Lahoz

10

1 reference

Europe PubMed Central

26 November 2017

Caelyx/KS Spanish Study Group

11

1 reference

Europe PubMed Central

26 November 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

26 November 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

26 November 2017

2

1 reference

Europe PubMed Central

26 November 2017

429-437

1 reference

Europe PubMed Central

26 November 2017

5

1 reference

Europe PubMed Central

26 November 2017

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8

1 reference

https://api.crossref.org/works/10.1310%2F700B-9QT3-HGN9-Q3FQ

21 January 2018

Identifiers

10.1310/700B-9QT3-HGN9-Q3FQ

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43775324&oldid=2103221173"